Evidence map›Paper›PMID 40991928›Full record

ArticleCell reports2025

E. coli-activated cellular circuit restrains intestinal inflammatory microbiota-specific T cells and protects against colitis.

Dasom V Kim, Amanda Chen, Charles Ng, Lisette Peres-Tintin, Seung-Eun Park, Monica Acosta, Ryann Callaghan, Nikketa Stanford, Miozzottys Perez-Rosario, Dean B Matthews and 2 more

Abstract read
In one paragraph

Article in Cell reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Dasom V KimImmunology Program of the Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA.
Amanda ChenImmunology Program of the Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA.
Charles NgCancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Lisette Peres-TintinImmunology Program of the Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Seung-Eun ParkImmunology Program of the Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Monica AcostaImmunology Program of the Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ryann CallaghanImmunology Program of the Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA.
Nikketa StanfordImmunology Program of the Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Miozzottys Perez-RosarioImmunology Program of the Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Dean B MatthewsImmunology Program of the Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA.
Daniel Zegarra-RuizImmunology Program of the Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Gretchen E DiehlImmunology Program of the Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA. Electronic address: diehlg1@mskcc.org.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
cGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of a Nanoparticle Based HIV Envelope Vaccine75N93022D00005 · NIAID · INTERNATIONAL AIDS VACCINE INITIATIVE · PI HASSELL, THOMAS · 2022 to 2025
$8.0M
Weill Cornell/Rockefeller/Sloan Kettering MST ProgramT32GM152349 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI KATHARINE C HSU · 2024 to 2026
$6.6M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00005 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WATSON, KAROL E · 2020 to 2025
$5.1M
Orchestrating intestinal immunity through microbiota-CX3CR1+ cell interactions R01AI125264 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI GRETCHEN E DIEHL · 2017 to 2026
$4.1M
Regulation of lupus pathogenesis through modulation of thymic development of pathobiont-specific T cellsK99AR080207 · NIAMS · SLOAN-KETTERING INST CAN RESEARCH · PI ZEGARRA RUIZ, DANIEL FERNANDO · 2022 to 2023
$184k
Regulation of Microbial Trafficking to the Thymus in Early LifeF31AI183752 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI Dean Matthews · 2024 to 2026
$149k
Investigating the Role of the Microbiome in Mononuclear Phagocyte FunctionF31AI181447 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI Amanda Chen · 2024 to 2026
$149k
NCI NIH HHS P30 CA008748NHLBI NIH HHS 75N92020D00005NIAID NIH HHS 75N93022D00005NIAID NIH HHS 75N93023D00005NIAID NIH HHS F31 AI181447NIAID NIH HHS F31 AI183752NIAID NIH HHS R01 AI125264NIAMS NIH HHS K99 AR080207NIDA NIH HHS 75N95020D00005NIGMS NIH HHS T32 GM152349ORFDO NIH HHS 75N99020D00005
6 · The paper itself

Abstract

Balance between microbiota-specific effector and regulatory T (Treg) cells is required to promote intestinal health and limit disease pathology. The pathways regulating T cell equilibrium during inflammation and the role of individual microbiota members in these outcomes are still being established. Here, we demonstrate that colonization with a single adherent-invasive Escherichia coli strain restrains pathogenic microbiota-directed T helper type 1 (Th1) cells. This results in a higher proportion of colon Treg cells, specifically tolerogenic microbiota-specific RORγt

Indexed as

ColitisEscherichia coliGastrointestinal MicrobiomeAnimalsCX3C Chemokine Receptor 1InflammationInterleukin-10MiceMice, Inbred C57BLTh1 CellsT-Lymphocytes, RegulatoryCX3C Chemokine Receptor 1Interleukin-10colitisCP: ImmunologyE. coliIL-10intestinal immunitymacrophagesmicrobiotamicrobiota-specific T cellspTreg cellsTh1 cells

Identifiers

PMID40991928
PMCPMC12667601

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.